Armistice Capital »

Nexgel shares owned by Armistice Capital

Quarter-by-quarter ownership of Nexgel (NXGLW) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Nexgel

Tip: Access up to 7 years of quarterly data

All positions including Nexgel held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nexgel by Armistice Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $396k 550k 0.72
2023-09-30 $187k 550k 0.34
2023-06-30 $238k 550k 0.43
2023-03-31 $105k 550k 0.19
2022-12-31 $83k 550k 0.15
2022-09-30 $165k 550k 0.30
2022-03-31 $245k 550k 0.45

More positions owned by Armistice Capital

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Ptc Therapeutics I (PTCT)
Cytokinetics Com New (CYTK)
Neurocrine Biosciences (NBIX)
Incyte Corporation (INCY)
Supernus Pharmaceuticals (SUPN)
Argenx Se Sponsored Adr (ARGX)
Deciphera Pharmaceuticals (DCPH)
Agios Pharmaceuticals (AGIO)
Immunovant (IMVT)
Sanofi Sponsored Adr (SNY)
Aurinia Pharmaceuticals (AUPH)
Dentsply Sirona (XRAY)
Travere Therapeutics (TVTX)

View all positions for Armistice Capital

Top funds holding Nexgel

Armistice Capital
Altium Capital Management
Clear Street

View all funds holding Nexgel